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Background: Introducing self-collected health data from patients with diabetes into consultation can be beneficial for both
patients and clinicians. Such an initiative can allow patients to be more proactive in their disease management and clinicians to
provide more tailored medical services. Optimally, electronic health record systems (EHRs) should be able to receive self-collected
health data in a standard representation of medical data such as Fast Healthcare Interoperability Resources (FHIR), from patients
systems like mobile health apps and display the data directly to their users—the clinicians. However, although Norwegian EHRs
are working on implementing FHIR, no solution or graphical interface is available today to display self-collected health data.
Objective: The objective of this study was to design and assess a dashboard for displaying relevant self-collected health data
from patients with diabetes to clinicians.
Methods: The design relied on an iterative participatory process involving workshops with patients, clinicians, and researchers
to define which information should be available and how it should be displayed. The assessment is based on a case study, presenting
an instance of the dashboard populated with data collected from one patient with diabetes type 1 (in-house researcher) face-to-face
by 14 clinicians. We performed a qualitative analysis based on usability, functionality, and expectation by using responses to
questionnaires that were distributed to the 14 clinicians at the end of the workshops and collected before the participants left. The
qualitative assessment was guided by the Standards for Reporting Qualitative Research.
Results: We created a dashboard permitting clinicians to assess the reliability of self-collected health data, list all collected data
including medical calculations, and highlight medical situations that need to be investigated to improve the situation of the patients.
The dashboard uses a combination of tables, graphs, and other visual representations to display the relevant information. Clinicians
think that this type of solution will be useful during consultations every day, especially for patients living in remote areas or those
who are technologically interested.
Conclusions: Displaying self-collected health data during consultations is not enough for clinicians; the data reliability has to
be assured and the relevant information needs to be extracted and displayed along with the data to ease the introduction during
a medical encounter. The prestudy assessment showed that the system provides relevant information to meet clinicians’ need and
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that clinicians were eager to start using it during consultations. The system has been under testing in a medical trial since November
2018, and the first results of its assessment in a real-life situation are expected in the beginning of next year (2020).
(JMIR Diabetes 2019;4(3):e14002)   doi:10.2196/14002
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Introduction
Personal health information, such as data generated by sensors
or data collected by patients themselves through their diaries,
contains important information regarding the people’s daily
lifestyle. Previous studies have shown that clinicians can use
these patient data to provide tailored medical services, especially
for patients with chronic diseases [1-3], and that 60% of the
patients are open to providing real-time access to their
self-collected health information [4]. The use of self-collected
data is especially relevant for patients with diabetes, because
they often have to adhere to complex treatment regimes. If, for
example, a patient is treated with insulin, the dosage has to be
adjusted in concordance with not only the calorie intake, but
also other factors such as physical exercise [5] and undercurrent
disease [6]. Patients with diabetes and physicians have
traditionally relied on analog diaries, but as personal computers
and smartphones have become commonplace, there has been
an explosive increase in the use of digital diaries and wearables
[7,8]. In addition, several research projects and private
companies are providing solutions to allow clinicians to consult
data collected by the patients themselves [2,9]. However, none
of these solutions are widely used, mainly because they are
proprietary and require specific hardware and software to collect
and access the data. This makes it difficult to provide fluid
integration between such devices and the physicians’ existing
tools and constitutes an important barrier of acceptance for the
introduction of these types of data [10].
This paper is part of the “Full Flow of Health Data Between
Patients and Health Care Systems” project, which focuses on
integrating self-collected health data into consultations in
Norway using diabetes and Fast Healthcare Interoperability
Resources (FHIR) as a case.
Major health care actors such as Epic Systems Corporation and
Cerner propose application programming interfaces relying on
FHIR standards [11,12]. Open source projects such as OpenMRS
and Open mHealth also provide access to FHIR resources
[13,14], and studies propose to use FHIR to improve the health
care sector [15]. Norwegian electronic health records (EHRs)
are currently working on implementing FHIR standards in their
respective solutions [16], but none of them are ready to manage
FHIR resources today, as they are not able to receive and display
FHIR data. We therefore provided clinicians with a standalone
dashboard (ie, view providing key performance indicators)
displaying the patients’ self-collected health data to be used as
an addition to their current EHR.
Even if self-collected data could be seamlessly integrated, user
acceptance is not guaranteed. Patients with diabetes can collect
large amounts of data. If the data cannot be presented in an
efficient way, it cannot be efficiently comprehended, severely
diminishing its usefulness [17-20]. Many physicians struggle
to obtain an overview of constantly expanding EHRs. The
introduction of a potentially large amount of new data that the
physicians are not used to utilizing must therefore be handled
with great care, as even minor ill-considered implementation
details can have a huge negative impact [18-20]. Optimal
presentation of health data depends on the information needed
by the clinicians. There is no optimal way of presenting clinical
data, because these needs vary a lot [21-25].
This paper presents the design of a dashboard for displaying
the self-collected health data from patients with diabetes and
describes how the user interface attempts to meet the clinicians’
information needs. Furthermore, the paper presents the prestudy
assessment of the dashboard by clinicians.
Methods
Phases
In the two main phases of the study, we used different
methodologies: iterative dashboard design and prestudy
assessment (Figure 1). The iterative design phase supported the
conception and implementation of the dashboard, while the
prestudy assessment was used to collect the clinicians’
experiences with the developed dashboard as well as their
recommendations.
Based on previous studies by the authors [26,27], we created
the first prototype of the dashboard to be used as a first input
for the iterative design process. The information collected from
the studies [26,27] was used to identify the data required during
diabetes consultations and to define the requirements for the
graphical user interface (GUI) of the dashboard.
Iterative Dashboard Design
The development of the dashboard followed a three-step iterative
process to approach the following primary objectives: (1)
identify the needs of both patients and clinicians regarding
information with clinical relevance during a consultation,
information suitable to be collected by patients, and how to
present the information in the GUI in order to improve its
usability during consultations; (2) evaluate early prototypes and
propose adjustments; and (3) develop prototypes based on the
proposed adjustments identified in step two.
To achieve these objectives, we organized facilitated workshops,
supported by open-ended discussions, to approach specific tasks
in rapid development cycles.
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Figure 1. The two main phases of the study, with their components and results.
Facilitated Workshops and Open-Ended Discussions
Facilitated workshops are sessions bringing users, stakeholders,
and partners together to define and evaluate product
requirements [28].
We organized two facilitated workshops using a participatory
design approach [29] involving four of the authors (AGi, AGr,
EÅ, and AH), four clinicians (two nurses and two doctors who
have worked with patients with diabetes), and two patients with
diabetes. The clinicians and patients were recruited by our
partner—the University Hospital of North Norway. Different
methodologies were used during these workshops, namely,
brainstorms, idea storms, and go-rounds, to balance creativity
and problem-solving tasks and to reduce the pressure on the
patients by allowing everyone to speak in turn. The facilitated
workshops lasted 3 hours each, and participants were invited
to use their own experiences to contribute to the workshops’
primary objectives. The majority group decision–making
technique was employed during these sessions.
In addition to the facilitated workshops, we organized a total
of 11 sessions with open-ended discussion—three focused on
mathematical models to use for medical and statistical
calculations and involved two computer scientists; four focused
on targeting the GUI usability, namely, the information to be
displayed, which was attended by one computer scientist and
one GUI expert; two focused on a first assessment regarding
the medical relevance of the information displayed, which was
joined by a computer scientist and a general practitioner; and
two focused on the evaluation of the dashboard prototype against
the requirements and involved four of the authors (AGi, AGr,
EÅ, and AH).
Scenarios
We used a simulation-type scenario approach to model real-life
situations and narratives [30]. The modelling process relied on
a taxonomy containing four elements that were used for each
scenario. These elements were as follows:
1. Settings: the context and the situation of the scenario
2. Agents: those who participate in the scenario
3. Goals: the functional targets of the scenario
4. Events: the actions taken by the agents during the scenario
The detailed information concerning the three main scenarios
was defined together with the participants during the first
facilitated workshop. We chose to use a scenario approach
because it facilitates the cooperation of the participants during
the facilitated workshops, who can see themselves in the
situations and evoke their own experiences, and it simplifies
the design process of the dashboard by providing concrete and
flexible situations [31].
Prototyping
The prototyping phase consisted of implementing the dashboard
to support the given scenarios by using computer-generated
data that express the data requirements for the scenarios.
The dashboard was then built to achieve the objectives described
in the scenarios. An agile development process [32] was
exclusively used for this task, as evolution, changes, and
adaptability were necessary, considering the continuous inputs
provided by the workshops. The implementation relied on Java
Enterprise Edition 8, Java Server Faces 2.2, and Glassfish 5.
The developed prototypes were assessed during the workshops
and improved during each iteration of the design process.
Once the authors and participants in the workshops decided that
the dashboard was satisfactory to be used in a real situation, we
stopped the iterative design process and selected the last
prototype for a prestudy assessment by different clinicians.
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Prestudy Assessment of the Dashboard by Clinicians
Protocol
The design of the prestudy assessment was guided by the
Standards for Reporting Qualitative Research checklist to
enhance the organization and reporting of this study [33]. The
aim of the prestudy assessment was to evaluate the pertinence
of the functionalities presented in the dashboard GUI and its
usability prior to a medical trial.
We used a case study approach, organizing a total of five
workshops in health care offices (hospital and general
practitioner [GP] office), each involving one to four clinicians,
accounting to a total of 14 clinicians, and one or two researchers.
The 14 clinicians were recruited through our partner, the
University Hospital of North Norway, or by direct contact
initiated by us; none participated in the dashboard design and
all are currently participating in the medical trial. We were
limited in the number of participants to include due to external
factors (eg, time constraints and unavailability of further
participants).
During the workshops, we presented the FullFlow system, which
included the last prototype of the dashboard, by using the
self-collected health data from one in-house researcher who has
type 1 diabetes (an exemption was obtained from the local ethics
committee: Ref 2018/719 [34]), hereafter referred to as Research
Patient. We extracted these data from the Research Patient’s
Diabetes Diary to fill the FullFlow system, using the Diabetes
Share Live solution to transmit the data in a way similar to that
used in a previous study [27]. The use case presented in the
workshops was based on the Research Patient’s real-life diabetes
data (ie, insulin intake, carbohydrate intake, blood glucose
values, physical activities, weight, medication, and personal
aims) and is similar to one scenario created in the dashboard
design process. The Research Patient participated in all
workshops, where he could explain the different values
displayed in the dashboard and answer questions regarding his
lifestyle and the recorded values.
Data Collection
During the workshops, we distributed a paper-based
questionnaire to the participants after presenting the system and
letting the clinicians test it. We then collected the questionnaires
at the end of the session. The first and second (AGi and EÅ)
authors designed a specific questionnaire based on the System
Usability Scale [35] and the Computer System Usability
Questionnaire [36].
We decided to use a custom questionnaire, as the assessment
did not permit inclusion of important usability factors due to a
lack of clinical context such as patient-clinician relationships.
Given that the questionnaire was administered to the participants
before the study, we wanted to provide open-ended questions
to obtain important feedback for this iterative process before
starting the medical trial. The questionnaire contained four
questions about the system and the role of the user (eg, nurse):
• Q1a: Do you think the system will be useful during
consultation? Q1b: Potential comments.
• Q2a: Would you like to have more information delivered
by the FullFlow system? Q2b: Potential comments.
• Q3a: Would you like to remove or hide information
currently delivered by the FullFlow system? Q3b: Potential
comments.
• Q4: Do you have any feedback you would like to offer?
Qualitative Analysis
The first author (AG) performed a qualitative analysis based on
three keywords: expectation, usability, and functionality. In our
context, we defined expectation as a general belief that positive
or negative outcomes could occur in clinical settings by using
our proposed system. The use of this term was inspired by the
work of Bialosky et al [37]. We used the seven notions provided
by Vázquez-García et al [38] to define usability: knowability
(user can understand, learn, and remember how to use the
system), operability (capacity of the system to accommodate
users with different needs), efficiency (capacity of the system
to produce appropriate results), robustness (capacity of the
system to resist error), safety (capacity of the system to avoid
risk), and satisfaction (capacity of the system to generate interest
in users). We used the definition proposed by Salleh et al [39]
to describe functionality: a set of functions and their specified
properties. We then used the feedback to improve the system
before starting the medical trial. We used the feedback obtained
in order to improve the system before starting the medical trial.
Results
Overview
From previous studies, we identified eight relevant data types
for diabetes consultation—blood pressure, calories,
carbohydrates, heart rate, blood glucose, insulin, weight, and
physical activity (Figure 2 A)—and relevant medical
calculations such as insulin-to-carbohydrate (I:C) ratio and basal
insulin to bolus insulin ratio (Figure 2 C). As a requirement for
the GUI, we identified the need to present the data in different
time frames (per hour, per day, per week, and for the complete
period [Figure 2 B]) and the use of a color scale to illustrate
data ranges (Figure 2 D).
Iterative Dashboard Design
Facilitated Workshops and Open-Ended Discussions
The first prototype was presented to the participants in the first
facilitated workshop. Based on this prototype and their own
experiences, the participants suggested improvements to both
data, functionalities, and GUI. The suggested improvements
were translated into requirements and implemented in the
prototype presented during the second workshop. The
improvements suggested during the second workshop were used
as requirements during the development of the final prototype.
The requirements identified are summarized in Table 1.
Scenarios
We created three main scenarios (Table 2); this was considered
a manageable number of scenarios for the workshops and
open-ended discussions while still allowing diversification of
the situations.
JMIR Diabetes 2019 | vol. 4 | iss. 3 | e14002 | p.4http://diabetes.jmir.org/2019/3/e14002/
(page number not for citation purposes)
Giordanengo et alJMIR DIABETES
XSL•FO
RenderX
Figure 2. First prototype of the FullFlow dashboard system.
Table 1. Summary of the requirements defined based on suggestions from the participants in the facilitated workshops and their description.
DescriptionRequirements
At least blood glucose, blood pressure, insulin (bolus/basal), medication, carbohydrates, calories,
and physical activity. Being able to accept new data types (eg, menstruation, ketones, and
polypharmacy) would be a plus.
The system shall inform clinicians if the patients register life goals (eg, what they are focusing
on in their daily self-management).
R1: Displaying data collected by patients
The system will notify which data have been collected by the patients and quantify them.R2: Quantify data collected by patients
The system will provide clinicians the length of time during which patients collected their data.R3: Displaying data collection period
The system will be able to present a variability value for all data types to indicate how much
these values diverge.
R4: Variabilities in the patients’ data values
The system will be able to provide medically relevant information (eg, insulin-to-carbohydrate
ratio and insulin sensitivity).
R5: Medical calculations
The system will permit clinicians to know immediately if the data collected by the patients are
reliable (ie, worth their time consulting the data).
R6: Grading data reliability
Removing eA1c from the graphical user interface.R7: Hiding eA1c
a
The system will use the simplified (3 levels) blood glucose range.R8: Reduce complexity of blood glucose ranges
The system will present all self-collected health data at once in a graph.R9: Consulting all self-collected health data at once
The system will ease identifying patterns in patients’ lifestyle per day, per week, and for the
whole period (eg, hyperglycemic events each day after dinner).
R10: Pattern recognition
The system shall provide information clinicians can assess by comparing existing data to the
self-collected health data.
R11: Bridge to existing data
The system will be able to inform clinicians about what the patients struggle with, what they
manage, etc.
R12: Overview of the patients’ situations
The system will provide information about which data are in and out of range.R13: Visual helper
aeA1c: estimated hemoglobin A1c.
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Table 2. Scenarios created to support the user requirements. Settings: the context and situation of the scenario. Agents: actors in the scenario. Goals:
targets of the scenario. Events: the actions taken by the agents during the scenario.
Scenario 3Scenario 2Scenario 1Taxonomy
Patient always has high fasting blood glu-
cose levels, despite being on medication
and following cooking courses. Patient
has a meeting with his general practitioner
after collecting 2 weeks of data.
Patient struggles with carbohydrate counting
and always ends up in hyperglycemia after
meals, despite using a hybrid closed-loop
system (continuous glucose monitor and a
pump). Patient also reaches hypoglycemic
levels after the insulin action (“yoyo” ef-
fect). Patient has an appointment with a di-
etitian after having collected 1 week of data.
Patient has nightly hypoglycemic events.
The patient has an appointment with a di-
abetes nurse to discuss his situation and
therefore collected health data for 1 month
prior to the appointment. The patient uses
finger pricks and an insulin pen.
Settings
Patient with type 2 diabetes and general
practitioner
Patient with type 1 diabetes and dietitianPatient with type 1 diabetes and diabetes
nurse
Agents
The system should show the high glucose
situations, the calorie intakes that are
above the recommended levels, the pa-
tient’s lack of physical activity, the high
blood pressure, and that the patient some-
times forgets to take his medication.
The system should show the relationship
between meal intakes, insulin-on-board
levels, and blood glucose levels.
The system should show the hypoglycemic
events and identify the nightly trends. The
system should show the insulin dosages
and the carbohydrate intakes to help the
nurse identify possible points of action.
Goals
Patient registers, on an average, per day:Patient registers, on an average, per day:Patient registers, on an average, per day:Events
••• 1 blood glucose value,288 blood glucose values,10 blood glucose values,
• ••4 carbohydrate intakes, 2 medication intakes, andhourly insulin bolus dosage, and
•• •5 carbohydrate intakes.6 insulin injections (2 basal, 4 bolus),
and
5 calorie intakes.
Patient also has:Dietitian discusses with the patient his
“yoyo effect” after meals and consults the
self-collected health data using the FullFlow
dashboard.
• 10 minutes of physical activity.
• 2 weight registrations,
Nurse discusses the patient’s hypo-
glycemic events with him and consults the
data using the FullFlow dashboard.
• 1 blood pressure registration, and
• 3 physical activity registrations (<10
minutes).
General practitioner discusses the situation
with the patient and uses the FullFlow
system to get an overview of his situation.
Final Prototype
We provide an example of the dashboard based on the
self-collected health data obtained from the Research Patient,
which was similar to the use case presented to clinicians in the
preassessment study. The proposed dashboard contains six main
sections accessible from a menu displayed at the top of the page
(Figure 3):
1. The Overview contains information regarding the data
reliability, the data collected, the patients’ personal goals,
and a list of noticeable events and their potential causes. It
is the landing page of a FullFlow report.
2. The Combined Data displays all the quantifiable data sent
by the patients in combination with the calculated
information for the whole period in a unique graph.
3. The Daily Distribution distributes all quantifiable data per
hour in multiple graphs (one graph per data type).
4. The Daily Evolution summarizes the data per day in
multiple graphs (one graph per data type).
5. The Time Period displays the data for the whole period in
multiple graphs (one graph per data type).
6. The Data List lists all the data collected by the patients in
a table.
Overview Section
The Overview section provides a summary of all data collected
by the patients and the results of the FullFlow analyses (Figures
4 and 5). The objective of this section is to provide an overview
of the patients’ situation and the medically related events found
to be important to discuss or address, without the need to consult
the whole data set. The first data displayed are the time period
(Figure 4 A), determined by the first and last FHIR artefacts
ordered by date. This addresses the requirement R3 (Table 1).
Figure 3. Dashboard menu.
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Figure 4. Overview section, part 1. (A) Title and period of time. (B) Data reliability. (C) Summary of the data. (D) List of all the data collected by the
patients. (E) Estimated hemoglobin A1c. (F) Blood glucose summary. (G) Time in range and time out of range for blood glucose registrations. (H)
Average daily values of data collected by the patients for the period. (I) Latest values for each type of data collected by patients.
The second dataset displayed is related to the reliability of the
patients’ self-collected health data (Figure 4 B). A
knowledge-based module (KBM) grades the reliability of the
self-collected health data based on the presence or absence of
registered data, potential errors in data values, inconsistencies
between data sources, the number of data registrations, and the
regularity of the registrations made by the patients. This service
addresses the requirement R6 (Table 1) by providing clinicians
information about the quality and reliability of data at an early
stage of consultation. In this example, the system graded the
data as reliable. The system provides a list of issues if the data
are graded as not reliable. We explained and illustrated this
system in a previous article [40].
The next subsection, the Data Summary (Figure 4 C), first
contains a table (Figure 4 D) listing all the patients’
self-collected health data with important calculations for diabetes
patients, such as insulin sensitivity and insulin to carbohydrates
ratio (I:C), if the data collected permit the calculation of these
components. These values are displayed side by side with the
ratios submitted by the patients, if available, permitting a simple
comparison. The table contains the number of registrations and
the average daily number of registrations per day for all types
of data collected. The table also provides the average of all the
values as well as the pooled SD per data type (called “average
deviation” for the clinicians, see Discussion). The pooled SD
is calculated using the formula:
...where nk represents the number of registrations for a day and
represents the variance for a day. We used the same approach
for appropriate data types (eg, not used for blood pressure where
the system considers only the latest registered value per day).
The table also contains specific diabetes rules, such as the
100/85 rule for estimating the insulin sensitivity (also called
“correction factor”) [41] or the 400 rule for estimating the
insulin-to-carbohydrate ratio [42]. Patients can also provide this
information, and in this case, both collected and calculated
values will be listed one above the other for easy comparison.
This table addresses requirements R2, R4, and R5 (Table 1).
The next dataset provided is the estimated hemoglobin A1c
(eA1c) value (Figure 4 E), calculated from the average blood
glucose value of all blood glucose registrations, based on the
formula proposed by Nathan et al [43]: eAGmmol/L=1.59*
A1c–2.59, where eAG is the estimated average glucose level in
mmol/L and A1c the hemoglobin A1c value. The system
calculates the eA1c only if there are at least 3 blood glucose
registrations a day and 21 blood glucose registrations in total.
This system provides two standards for the eA1c value—National
Glycohemoglobin Standardization Program (NGSP; %) and
International Federation of Clinical Chemistry and Laboratory
Medicine (IFCC) (mmol/mol)—considering that Norway
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replaced NGSP with IFCC in 2018 [44]. To convert NGSP to
the IFCC value [44], we use the following formula:
This service addresses the requirement R11 (Table 1) by
providing a possible comparison between self-collected health
data and laboratory results. However, it also conflicts with the
requirement R7 (Table 1). Therefore, we decided to hide these
values during the medical trial.
The blood glucose summary (Figure 4 F) displays the average
blood glucose value and the pooled SD (same values as in Table
1). The blood glucose values per range (Figure 4 G) display the
number of registrations and their percentages per range (low,
on target, or high), which are defined as per the standards
[45,46]. This addresses requirement R8 (Table 1).
The average daily values (Figure 4 H) display the average of
all collected data when appropriate (same values as in Table 1).
The final dataset displayed is the last value for each data type
the patients have registered (Figure 4 I).
FullFlow grades each piece of information presented in Figure
4 E-I and provides four background color states: green, orange,
red, and white. These colors have different meanings: green
indicates that the value is in the recommended range, orange
indicates that the value is slightly above or under the
recommended range, red indicates that the value is out of range,
and white indicates that a value is not graded because of a lack
of standards or that the value depends heavily on context. The
visual representation is inspired by the work of Sim et al [47],
who are using a similar grading system, and the work of
Diagliati et al [48], who used traffic lights. This grading
addresses requirements R13 and R12 (Table 1).
Figure 5. Overview section, part 2. A: List of personal goals defined in the patients’ diary. B: Example of a personal goal. C: List of noticeable events
based on the collected data. D: List of events detected organized by type. E. Distribution of event types per day and per hour. F: Example of a noticeable
event.
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Next, the overview section contains personal goals (Figure 5
A) defined by the patients with or without clinician involvement.
Personal goals can be measurable (eg, keeping your blood
glucose level between 4 and 10 mmol/L [Figure 5 B]) or
nonmeasurable (eg, more proactive). FullFlow provides progress
and description for measurable goals. Displaying personal goals
addresses requirement R1 (Table 1).
The next section provides information about noticeable events
(Figure 5 C). Noticeable events are important events that
clinicians and patients should address to improve the health
situation of the patients. FullFlow identifies them using KBM
in combination with the patients’ self-collected health data and
statistical calculations. FullFlow first summarizes the noticeable
events by displaying the number of occurrences (Figure 5 D)
and distributing the events during the day and the day of the
week based on the time, to potentially identify trends (Figure
5 E). Subsequently, FullFlow displays one event at a time,
ordered from the most to the least serious, and provides potential
causes and explanations for them (Figure 5 F). This section
includes other medical conditions related to blood pressure or
sleeping pattern in addition to hypoglycemic and hyperglycemic
events shown in Figure 5. We described the KBM in detail in
a previous article [40]. Noticeable events address requirement
R12 (Table 1).
Combined Data Section
The combined data section presents all the quantifiable data
available in FullFlow (self-collected health data and
calculations), as shown in Figure 6. This graph is based on the
Highstock library [49] and addresses requirement R9 (Table 1).
Clinicians can change the timeframe by selecting a start and an
end date (Figure 6 B) and selecting a predefined time length
such as 3 days or 1 week (Figure 6 A) or by sliding, extending,
or narrowing the data range selector (Figure 6 D). Clicking on
a data type in the lowest part of the graph hides or shows the
data type in the center of the graph, allowing clinicians to focus
on what they would like to analyze (Figure 6 E). The vertical
axes are built automatically (either left or right, Figure 6 C and
6C’) depending on the data type available. The frequency of
measurements or the data type extracted from Logical
Observation Identifiers Names and Codes or the Systematized
Nomenclature of Medicine Clinical Terms contained in FHIR
artefacts define the data representation in the graph. Series
represent data types having at least 20 registrations per day or
being of a specific type, such as blood glucose, while bars
represent the rest. Areas represent the reference range of the
FHIR artefacts (eg, in-range for blood glucose values) linked
to a data type. A mouse hovering above a point shows the exact
time and value for all data types with the exact same time. We
used the OpenAPS approach to calculate the insulin on board
(IoB) [50] and the work of Dana Lewis [51] to calculate the
carbohydrates on board (CoB).
Figure 6. Combined data. (A) Period selection by predefined time length. (B) Period selection by dates. (C, C'): Multiple y-axes. (D) Period selection
by range selector. (E) List of all data types represented in the graph.
JMIR Diabetes 2019 | vol. 4 | iss. 3 | e14002 | p.9http://diabetes.jmir.org/2019/3/e14002/
(page number not for citation purposes)




The daily distribution section distributes all the available data
in a single day to help clinicians identify daily patterns
(requirement R10 in Table 1), such as hypoglycemic events
during the nights or hyperglycemic events during the afternoon.
This section proposes one graph per data type (Figure 7), which
displays all the blood glucose measurements available in a single
day. In this example, only finger prick registrations are shown.
In addition to displaying the data, FullFlow calculates a moving
average of all the values. FullFlow uses either a simple moving
average or a weighted moving average, depending on the data
type and how patients have collected them (see Discussion for
more details). This type of graph also contains reference ranges
when provided.
Daily Evolution Section
The daily evolution section simply presents the sum, the average,
or the latest data per day for the whole period, depending on
the data type (Figure 8). For instance, blood glucose values are
averaged per day, insulin amount values are summed per day,
and the latest of the blood pressure values of the day are used
for each day. This type of graph also contains reference ranges
when provided. Each data type has its own graph.
Time Period Section
The time period section shows all data available for the whole
period by using the same approach as the combined data, except
that one graph contains only one data type (Figure 9).
Data List Section
The data list section presents extracted information from all
health data self-collected by patients in a list, without the
calculated values of the FullFlow, as shown in Figure 10. The
section displays the number of registrations made by the patients
and shows the date, data type, value, unit, and comment for
each entry. Clinicians can order the table by clicking on the
head of a column (eg, ordering data per data type) or look up
specific registrations using the search field (top right in Figure
10).
The different sections in this dashboard permit the display of
any type of data collected by the patients and addresses the
requirement R1 (Table 1).
Figure 7. Daily distribution of blood glucose values.
Figure 8. Daily evolution of the blood glucose for the whole period.
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Figure 9. Time period for blood glucose values.
Figure 10. Data list section.
Prestudy Assessment of the Dashboard by Clinicians
This section presents the assessment of the full system (a
combination of the Diabetes Diary [52], Diabetes Share Live
[27], and FullFlow) by clinicians, following the approach
described in the Methods section. As mentioned in the previous
section, the graphical interface was presented without the eA1c
value displayed in Figure 4. Multimedia Appendix 1 contains
the transcribed answers to the collected questionnaires. The
following subsections present the results of the analyses of the
questionnaires organized using the taxonomy defined in the
Methods section (Data Collection subsection) and concerning
the FullFlow system only (the Diabetes Diary and Diabetes
Share Live are outside the scope of this study).
Participants
Fourteen clinicians participated in the prestudy assessment: nine
(64.3%) were GPs, four (28.6%) were diabetes nurses, and one
(7.1%) was a dietitian.
Pertinence of the Functionalities Provided by the
FullFlow System
Regarding the relevance of the functionalities provided by the
system, the overwhelming majority of the participants (9/14,
64.3%) considered them relevant and would like to keep the
system in the current state, without adding or removing any
functionalities, as shown in Table 3. Five (35.7%) participants
would have liked to add or remove one or more functionalities
in the system. Although the majority of the primary health care
personnel (GPs) were satisfied with the information available
in the system (7/9 or 77.8% would like to keep the system in
its current state, while 2/9 or 22.2% would like to alter it), the
situation was less clear for the secondary health care personnel
(nurses and dietitian), with three (of 5, 60%) clinicians wanting
to adjust functionalities and the other two (40%) not wanting
to change the system. Regarding functionality alterations, five
clinicians proposed 11 points to improve the system and offer
more pertinent data (Figure 11).
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Table 3. Clinicians’ evaluations of potential required adjustments to FullFlow, categorized by the results of the evaluation (to keep or adjust functionalities)
and by clinical role (general practitioner, diabetes nurse, and dietician).
Total, n (%)Dietitian, nDiabetes nurse, nGeneral practitioner, nRole
5 (36)122Adjust functionalities
9 (64)027Keep functionalities
Figure 11. Sankey diagram of the functionality adjustments proposed by the clinicians. Each color corresponds to a specific type of adjustment. Orange:
new service; lilac: new data type; light green: remove functionality; green: add functionality; dark green: proposed functionality adjustment. The numbers
represent the number of times an adjustment was mentioned. BG: blood glucose; IoB: insulin on board; CoB: carbohydrates on board; I:C: insulin to
carbohydrate ratio.
Of the eleven functionality adjustments proposed, nine (of 11,
81.8%) were related to adding new functionalities and the other
two (18.2%) were related to removing functionalities. Proposals
for adding new functionalities were divided into two subgroups:
new services (n=4) and new data types (n=5). New data types
would require adding data types not available in the system
when they were presented to the clinicians, while adding new
services would mean creation of new functionalities using the
data currently available in the system. Of the suggested new
data types, insulin type (eg, slow or fast acting) was mentioned
twice by clinicians, with the suggestion that it be available in
both the overview section and the graphs. The other data types
suggested were blood pressure, plasma glucose, and lipids. Of
the suggested new services, clinicians twice expressed the desire
to enter goals and notes directly into the Diabetes Diary of the
patients through the FullFlow system. Another clinician
requested more detailed blood glucose ranges such as high
hypoglycemia in the overview section, and a second suggested
displaying I:C values by time of the day (eg, fasting, morning,
afternoon, and night). Depending on the situations of the
patients, these new data types and services could “help provide
more tailored advice” and “facilitate cooperation with the
patients,” according to the clinicians. Of the functionalities
suggested for removal, one clinician proposed removing IoB
and CoB from the graphical interface, suggesting that “they will
not have time to investigate this data.”
Figure 12 shows the correlation between the suggested
adjustments and clinical roles. The data show that adjustment
needs were disjointed between the primary and secondary health
care personnel: The former group expressed the need to add
blood pressure, plasma glucose, and lipids to the functionalities
of the FullFlow system (mentioned once each), while the latter
group did not need them. The secondary health care personnel
group proposed adjusting the services available in FullFlow,
while the GPs focused only on new data types.
The needs of the dietitian and diabetes nurses intersected, with
the proposal of writing goals and notes directly in the Diabetes
Diary of the patients via the FullFlow system (mentioned once
per group). The nurses proposed recording the insulin type
(mentioned twice) and a more detailed blood glucose range
(mentioned once) in the FullFlow system. The dietitian was the
only clinician to suggest removing features from the FullFlow
system (IoB and CoB) and displaying the I:C values by time of
the day.
Usability of the FullFlow System
One clinician pointed out the possibility of the system being
time consuming during consultation, which could reduce its
efficiency. Querying the robustness of the FullFlow system,
one participant noted that insulin and carbohydrate intake times
should be matched in the Combined Data graph. A bug resulting
in movement of registrations on the time axis (x) when hiding
or showing data types (Figure 6 E) was corrected, and
registrations having the same time were shown close to each
other.
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Figure 12. Matrix presenting the correlation between the suggested adjustments and clinical roles (general practitioner, diabetes nurse, and dietitian).
The columns represent the clinical roles and use the same color coding as the previous figures (D/orange: dietitian; N/beige: diabetes nurse; GP/grey:
general practitioner). The rows represent the adjustments proposed by the clinicians and follow the same categorization and color coding as the previous
figure (light green: remove functionality; beige: new service; lilac: new data type). (-) denotes a proposed functionality removal, while (+) denotes a
proposed functionality introduction. The dark grey circles represent a suggested adjustment by a specific clinical role and the number of times it was
mentioned by that role. The vertical lines represent logical sets, while the horizontal lines denote the intersections of the logical sets, like a Euler diagram.
BG: blood glucose; IoB: insulin on board; CoB: carbohydrates on board; I:C: insulin-to-carbohydrate ratio.
Expectations and Summary
All the participants (14/14, 100%) expected that the presented
system—a combination of the Diabetes Diary, Diabetes Share
Live and FullFlow—would be useful during their daily
consultations. They forecast that the system would be good for
all patients, but particularly effective if patients enter enough
data regularly in their diaries.
They predicted that three types of patients would be interested
in this solution: (1) patients who are interested in technology
and self-management; (2) patients concerned about their diabetes
and quality of life; and (3) patients living in remote areas, where
the usage of the system could support remote consultations and
avoid patients travelling several hours for a single face-to-face
consultation. One participant mentioned that several patients
already use self-management apps, which would ease the
introduction of this system.
Overall, the system was very well received by the participants
and they were eager to start using it during consultations.
However, the participants mentioned that experience using the
system will be needed to validate their expectations and clarify
the system’s usability and functionality.
Discussion
Principal Results
This paper presented a dashboard for displaying patients’
self-collected health data during consultations, using diabetes
as a case example. The graphical interface was implemented
using continuous feedback from clinicians and patients to
minimize possible future user resistance by providing relevant
information to meet clinicians’ needs. We limited the potential
increase in time consumption due to the usage of this solution
by proposing information related to the quality of self-collected
health data (identifying whether the data are worth consulting),
displaying an overview of the situation of a patient, and
identifying important medical events without the need to consult
the complete data set.
The prestudy assessment showed that the solution could be
effective during consultations, especially if patients live in
remote areas or are interested in either mobile technologies or
improving their life conditions. The majority of clinicians were
satisfied with the current state of the graphical interface, and
all clinicians were eager to start using it.
The prestudy assessment also showed that the needs of primary
and secondary health care personnel are disjointed: GPs do not
need the same data and services as diabetes nurses or dietitians.
However, due to the limitations of the Diabetes Diary (see
below), their wishes cannot be fulfilled.
Dashboard Functionalities and Graphical User
Interface
The information provided by the KBM module, namely, the
grading of the self-collected health data (Figure 4 B), the
identification of trends (Figure 5 C-E), and the identification
of potential causes of medical events (Figure 5 F) address two
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of the main barriers of acceptance of introducing self-collected
health data into consultation, namely, the distrust of this source
of data [53-56] and a time increase in consultation.
The calculations presented in the overview table (Figure 4 D)
can facilitate diabetes management [57-60] for both patients
and clinicians. We chose to use a table for representing this
information, considering that clinicians are accustomed to using
tables for visually representing data, which can surpass graphs
in certain conditions [61]. We used a standard pooled deviation
for illustrating the variability of data type, considering that
diabetes, as a chronic disease, is a day-to-day management
disease and that a routine (ie, less variability of medical values)
can improve the condition of patients drastically [62,63]. For
instance, a low glucose variability is more important for diabetes
patients than having an in-range hemoglobin A1c for preventing
complications [64]. Therefore, providing an indication about
how much patients are able to stabilize their blood glucose
values during each day is important for them. Although previous
studies proposed several methods for measuring glucose
variability using SD, coefficient of variability, mean amplitude
of glycemic excursion, or continuous overall net glycemic action
with CGM, there is a lack of consensus on which method should
be used [64,65]. Moreover, these methods have drawbacks when
using self-monitoring blood glucose values due to a lack of
sufficient and regular number of measurements. Since our
system uses available data either from CGM, self-monitoring
of blood glucose, or a combination of the two, we are looking
for a generic model that can work for all types of available data
from the patient. It is quite optimistic to assume that patients
self-register data regularly every day, because it reminds them
that they are sick [66]; we used pooled SDs to weight the
average of each day’s SD. This weighting gives larger groups
(days with more registrations) a proportionally greater effect
on the overall estimate of the variability [67] and allows us to
increase the robustness of statistical calculations. Clinicians
agreed to use this approach. Another point to discuss is our
decision to use the more accessible term “average deviation”
instead of “pooled SD.” We believe that this term will prevent
patients and clinicians from being exposed to mathematical
concepts in order to understand the value. However, the
complete definition, with the formula and explanations of the
term, is presented to users if they hover the mouse over the
“average deviation” term. Moreover, we expect feedback on
this taxonomy from the medical trial.
We decided to use the eA1c functionality, although its use is
contested by some authors [68,69] for allowing clinicians to
compare the eA1c with the hemoglobin A1c results of the
laboratory tests, since previous studies showed that there is a
correlation between the hemoglobin A1c and eA1c values [70].
An important deviation between these two values could indicate
a poor quality and reliability of the self-collected health data
due to, for example, an insufficient number of registrations per
day and can therefore be used as one of the indicators of the
quality and reliability of the self-collected health data. Today,
due to technical restrictions, the FullFlow system cannot
integrate EHRs’ data and display the hemoglobin A1c value side
by side with the eA1c. Clinicians can consult the hemoglobin
A1c values in their EHRs and use FullFlow for consulting the
eA1c. In addition, this approach is used by the American
Diabetes Association [71] and MySugr [72] and is cited in the
NGSP’s website [73]. However, we decided to hide the eA1c
value, considering that clinical workers were concerned that
this value can confuse patients in Norway. Nonetheless, the
system will still collect the value, allowing us to compare the
calculated values against the laboratory test results or the
hemoglobin A1c values reported through questionnaires, to
determine how this approach fits real situations. The dashboard
containing the eA1c may be of interest to clinicians, patients,
researchers, and computer scientists.
Regarding the grading of each piece of information (Figure 4
E-I), the system uses different approaches depending on the
type of data. For instance, the FullFlow relies on medical
standards given by the Norwegian Directorate for Health [74]
and international public entities [75] (eg, hemoglobin A1c values)
or values we defined during our workshops (eg, grades for the
blood glucose in-range values). Some values are not graded,
such as the daily amount of insulin used, because each patient
follows tailored insulin therapy, depending on physiological
conditions such as weight as well as lifestyle factors such as
meal times and physical activity [76].
Displaying the patients’ personal goals in the overview section
(Figure 5 A) before the noticeable events will help the patients
steer the medical consultation toward what they would like to
discuss with their clinicians, as some of them are too shy to
interrupt the clinicians directly, according to the feedbacks
collected in the workshops.
The moving average and weighted moving average used by the
daily distribution section (Figure 7) further facilitate the visual
detection of patterns by clinicians, which can be useful for
improving patients’ lifestyle [77,78]. We are aware of other
types of moving averages such as the exponential weight moving
average [79] or the Hull moving average for reducing lag [80].
However, we decided to use a simple weighted moving average
in the first version of the FullFlow. The decision regarding the
usage of a weighted or simple moving average relies on the
analysis of the FHIR artefacts. For instance, a blood glucose
value obtained from a finger prick has twice the weight of a
blood glucose value measured with a CGM, considering that
finger pricks are more accurate than the CGMs, which require
calibration [81]. The window size for calculating the moving
average is set to five registrations to suppress the sheer power
the CGM readings have over the self-monitoring blood glucose
measurements (ie, five registrations maximum are used for
calculating one value of the weighted moving average). This
fact remains true even though the CGMs are becoming more
accurate [82] and some do not require calibration at all [83].
Comparison with Previous Studies
The dashboard we proposed differs from others such as MySugr
[84], the dashboard of Diagliati et al [48], Carelink by Medtronic
[85], the clinical decision system by Sim et al [47], the system
proposed by Martinez-Millana et al [86], and the platform
proposed by Fico et al [87]. The main differences are listed
below:
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1. FullFlow does not limit the integration of data to specific
companies or types of sensors: finger pricks, CGMs, insulin
pens or insulin pumps can all be used by the patients.
2. FullFlow analyzes the data and proposes recommendations
regarding potential causes of medical situations.
3. FullFlow provides indicators regarding the reliability of the
self-collected health data.
4. FullFlow empowers patients by introducing their personal
goals in the medical consultation.
Limitations
The first limitation is the size of the sample for the design and
prestudy assessment phases, in which 18 clinicians and 2
patients participated. Although the sample did not permit
involvement of all types of clinical roles to identify their needs
and evaluate the graphical interface according to their
preferences, it was sufficient for determining that the dashboard
is ready to enter a medical trial.
During the prestudy assessment, one of the clinicians mentioned
that (s)he was afraid that the system could be time consuming.
Although the KBM can, in theory, address this issue, as we
explained in a previous article [40], we fear this challenge will
greatly impact the medical trial due to the technical solutions
chosen.
We know that the chosen patient platform, the Diabetes Diary,
is not the optimum app for all diabetes patients, as it lacks
important features such as the insulin type, blood pressure,
polypharmacy, and integration into glucometers and physical
activity trackers for automatic data transmission. These missing
features might result in a degradation of the reliability of the
data and experience for the patients as well as for the clinicians,
who would like to have access to these missing data, as specified
in the Prestudy Assessment section. Moreover, the Diabetes
Share Live solution platform, which requires many steps to be
performed during consultation for viewing the self-collected
health data, could degrade the experience of the users. This
platform requires eight steps to share the data: (1) patients open
the Diabetes Diary, (2) patients wait for the application to give
a unique identification code, (3) clinicians open an Internet
Navigator, (4) patients give clinicians the unique code, (5)
clinicians enter the code on the Webpage, (6) clinicians choose
a time period, (7) patients acknowledge the time period given
by the clinicians and select the data they want to share, and (8)
clinicians consult the FullFlow.
However, the FullFlow system itself is not affected by these
limitations and can accept data from several applications and
several operating systems. For example, while the insulin type
will not be displayed during the medical trial (the system
displays “Insulin Unknown”; Figure 4 D and 4 H), the FullFlow
differentiates types of insulin and treats them differently when
such information is available. Figure 13 shows an example of
different insulin types for data collected using the MySugr app,
where bolus and basal insulin types are treated as separate
entities and combined to calculate the IoB by using different
profiles [50]. Multimedia Appendix 2 shows an instance of the
dashboard populated with other data types and demonstrated
that the system is able to display any FHIR data.
Nevertheless, the medical trial will still allow us to conduct
research on the relevance of the information displayed, its
potential impact on medical services, and the relevance of the
KBM. Although the approach and business rules of the KBM
are trusted by the clinicians who were involved in its creation,
the medical trial will measure trust in the system during its
usage, which will depend on the situation of the patients and
the data collected by them. It could also be suitable for remote
consultation.
The last limitation concerns the integration of EHR data into
FullFlow, which, while planned, is not yet available. Therefore,
FullFlow cannot directly show EHR data, such as hemoglobin
A1c, and clinicians will have to use both systems during
consultations. However, while not reaching its maximum
potential, FullFlow will still permit the study of the integration
of self-collected health data into consultations.
Future Research
The graphical interface can still be improved in different ways:
The table in the Data Summary section could contain
information related to the in-range values of each data type and
be visually graded like the rest of the overview page (green,
orange, red, and white). Shortcuts to the combined graph from
a noticeable event could be made, with automatic selection of
data to display or hide. It may also be possible to see
self-collected health values day by day, with the current day
values displayed in a large graph at the top of the page and all
other days’ values listed under this graph as smaller graphs, one
per day; we could also add daily computational glucose
variability using SDs to the top of the overall graph.
We believe that the results from the medical trial, in which
clinicians use FullFlow in their daily consultations, are necessary
to assess what information is useful to add or remove, before
changing the graphical interface. Nevertheless, we believe that
the proposed dashboard is a viable temporary solution, and
ensuring interoperability of the data using standards and
terminologies will allow the independence of the EHRs and
permit users to display the information in the ways that benefits
most of their users.
The graphical interface could also be improved by adding dual
signaling for visually impaired people. For instance, the data
summary table in the overview section could integrate visual
cues, such as equals signs or arrows pointing up or down, to
indicate whether values are in range or out of range. These signs
could be added below the values displayed in circles in the
overview section or even used as texture.
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Figure 13. Example of data list and combined data with different types of insulin.
In addition, reports do not contain information regarding the
patients themselves (eg, names or identity numbers). This is
due to the usage of the Diabetes Diary and Diabetes Share Live.
It will not affect the medical trial, given that clinicians and
patients use the system in real time together and clinicians can
export the reports to their EHRs, where the patient will already
be selected. Notably, clinicians would like to write goals or
notes directly into the patients’ apps using the FullFlow system,
which is outside the scope of the study at this stage; we would
suggest that patients use their mobile apps themselves to directly
create the goals defined in collaboration with their clinicians
during consultation.
Although the system can read and display any data types as
long as they are in an FHIR format, it will use only “registered”
data types for advanced services (eg, blood glucose, insulin,
blood pressure, and menstruation), such as grading data
reliability or exploring potential causes of medical events. The
registered data types are listed in another article [40]. We plan
to add new business rules for new data types in the future, such
as lipids (as requested by a clinician) or foot temperature for
early detection of injuries due to diabetic neuropathy.
Multimedia Appendix 2 shows an example of the graphical
interface containing lipids as “unregistered” data type and six
registered data types.
Conclusions
The designed dashboard could ease the introduction of
self-collected health data during medical consultation by
providing relevant information about the situation of the patients,
the reliability of the data, and important medical events without
the need to consult the data in details. Moreover, the designed
dashboard could be an effective solution for face-to-face and
remote consultations.
A medical trial, started in November 2018, will provide medical
context and document user experience and medical outcomes
through usage logs, interviews, and surveys and will help us
adjust and improve the dashboard in terms of its graphical
interface and functionalities. The results are expected in the
beginning of 2020.
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CGM: continuous glucose monitor
CoB: carbohydrates on board
eA 1c: estimated HbA1c
EHR: electronic health record
FHIR: Fast Healthcare Interoperability Resources
GP: general practitioner
GUI: graphical user interface
I:C: insulin-to-carbohydrate ratio
IFCC: International Federation of Clinical Chemistry and Laboratory Medicine
IoB: insulin on board
KBM: knowledge-based module
NGSP: National Glycohemoglobin Standardization Program
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